Balentine LLC’s Molina Healthcare MOH Stock Holding History

Balentine LLC’s Portfolio MOH Stock Details MOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-572	Closed	-$235K	–	418
2024 Q1	$235K	Buy	+572	New	+$222K	0.01%	452

Other funds holding MOH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Balentine LLC's MOH Position: Q2 2024 in Review

Balentine LLC sold out of Molina Healthcare (MOH) in Q2 2024, closing a stake of 572 shares — an estimated $235K sold.

Balentine LLC first reported a position in MOH in Q1 2024 and held it in 1 quarter. The position peaked at $235K in Q1 2024. 641 funds tracked by Wall St. Rank hold MOH as of Q2 2024.

Balentine LLC reported no remaining Molina Healthcare position as of Q2 2024 after selling out during the quarter.
Balentine LLC sold 572 Molina Healthcare shares in Q2 2024, an estimated $235K.
Balentine LLC first reported a position in Molina Healthcare in Q1 2024 and held it in 1 quarter.
Balentine LLC's Molina Healthcare position peaked at $235K in Q1 2024.
641 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.